TAKEDA'S ZASOCITINIB LANDMARK PHASE 3 PLAQUE PSORIASIS DATA SHOW PROMISE TO DELIVER CLEAR SKIN IN A ONCE-DAILY PILL, CATALYZING A NEW ERA OF TREATMENT
Further company coverage: [ ]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.